Labiotech.eu

News and Trends 30 Oct 2017

German Pharmacist Finds a Way to Put the Brakes on Gallbladder Cancer

Research has identified a protein that drives tumor growth, which opens up a new therapeutic target for gallbladder cancer. Gallbladder cancer is often detected too late to be treated effectively as it shows few symptoms. Research, published in Oncotarget, has identified a pathway that could help to improve prognosis and treatment of the disease. Sonja Kessler discovered […]

October 30, 2017 - 3 minutesmins - By Alex Dale

Theranexus IPO CNS Narcolepsy Parkinsons Alzheimers

News and Trends 30 Oct 2017

French Biotech Closes €19M IPO to Treat Narcolepsy and Alzheimer’s

Theranexus debuts on Euronext Paris raising €19.6M that will support the development of its pipeline of CNS drugs for narcolepsy, Parkinson’s, Alzheimer’s and neuropathic pain. Theranexus, based in Lyon, starts trading on Euronext Paris today. The company starts off with a market cap of €47.5M after closing a €19.6M IPO. With the money raised, the company […]

October 30, 2017 - 4 minutesmins - By Clara Rodríguez Fernández

dragan grabulovski interview covagen acquisition

Interview 30 Oct 2017

Meet the Covagen Co-Founder that Closed Europe’s Biggest Acquisition in 2014

Dragan Grabulovski co-founded the biotech that became 2014’s largest acquisition in Europe. I caught up with him to hear about the journey and what happens to a founder after his or her company is acquired. Dragan Grabulovski was doing a PhD in pharmaceutical sciences at ETH Zurich in the group of Dario Neri when he […]

October 30, 2017 - 9 minutesmins - By Evelyn Warner

News and Trends 28 Oct 2017

Biomaterials Take the Stage at Dutch Design Week

The Dutch Design Week featured several biodesign projects that explore how the future will be shaped by the advance of biotechnology. Let’s have a look at some of them. Celebrated annually in Eindhoven, the Dutch Design Week has become a hotspot where designers share the latest trends and technologies. In the last few years, biodesign […]

October 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 27 Oct 2017

French Biotech Gets Together with L’Oréal to Clean up our Streets

Carbios and L’Oréal have had enough of the plastics bags and packaging littering our streets and will form a consortium for the bio-recycling of plastic on an industrial scale. Today, you’ll struggle to walk along a street without seeing plastic bottles, bags, and wrappers dropped by the wayside… but thankfully, help is at hand. Carbios, […]

October 27, 2017 - 3 minutesmins - By Alex Dale

More News! 27 Oct 2017

Lack of Permanent Academic Roles is Frightening News for PhD Students

With Halloween around the corner, PhD students probably felt safe from any nasty surprises for a few more days but their careers in academia may have hit a snag. PhD students work very hard, but surely it is all worth it for the guarantee of a good job at the end of it all? A study […]

October 27, 2017 - 3 minutesmins - By Alex Dale

News and Trends 26 Oct 2017

The FDA Recruits British Organs-on-Chips to Speed Up Drug Development

CN Bio Innovations and the FDA have entered a research collaboration to better predict drug safety in drug development by using human organs-on-chips. CN Bio Innovations, a spin-out from the University of Oxford, will be working with scientists from the FDA’s Centre for Drug Evaluation and Research with the aim of integrating organ-on-a-chip technology in the […]

October 26, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 26 Oct 2017

New and Improved CRISPR: More Precise Genome Editing Now Possible

US Scientists have developed a new form of CRISPR, base editing, which can repair tiny genome segments, smaller than a single gene. Here at Labiotech, we focus on European biotech, but this was too big to miss: Researchers based at MIT and Harvard have described a new way of editing DNA and RNA — base […]

October 26, 2017 - 3 minutesmins - By Alex Dale

News and Trends 26 Oct 2017

Here’s a Flashy New Technique to Model Disease

Although we have come very far in understanding cells and their functions, many undiscovered characteristics still keep us in the dark. Creating experiments that mimic the cell’s in vivo environments as closely as possible is one of the many challenges researchers face when working with cells in their labs. Micropatterning is a technique that addresses […]

October 26, 2017 - 7 minutesmins - By External Contributor

Interview 26 Oct 2017

Meet John Beadle, the Serial Entrepreneur with the Key to Oncolytic Viruses

Serial entrepreneur John Beadle is now at the helm of PsiOxus, an Oxford biotech with some promising virus-based cancer treatments. Oncolytic viruses have been around for a while without much to show for themselves besides Amgen’s Imlygic, but PsiOxus, one of our top Oxford biotechs, has some ideas to make them bear fruit. The company […]

October 26, 2017 - 8 minutesmins - By Evelyn Warner

News and Trends 25 Oct 2017

Shire’s Hemophilia Gene Therapy Boosted by Orphan Drug Designation

The FDA has granted orphan drug designation to Shire’s hemophilia A gene therapy, giving it the boost it needs to catch up with others in the field. Shire specializes in the development of drugs for rare diseases, including hemophilia A – a bleeding disorder caused by a lack of clotting factor VIII activity in the […]

October 25, 2017 - 1 minutemin - By Alex Dale

nanoparticles cancer thermotherapy UK2 1

News and Trends 25 Oct 2017

British Researchers Develop Clever Nanoparticles to Kill Cancer Cells

The University of Surrey has developed nanoparticles that heat up to kill cancer cells, but can then be controlled to protect healthy tissue. Research from the University of Surrey, published in Nanoscale, has been put forward as a new form of thermotherapy. Although it has been available for a long time, thermotherapy’s use is limited by […]

October 25, 2017 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

German Pharmacist Finds a Way to Put the Brakes on Gallbladder Cancer

French Biotech Closes €19M IPO to Treat Narcolepsy and Alzheimer’s

Meet the Covagen Co-Founder that Closed Europe’s Biggest Acquisition in 2014

Biomaterials Take the Stage at Dutch Design Week

French Biotech Gets Together with L’Oréal to Clean up our Streets

Lack of Permanent Academic Roles is Frightening News for PhD Students

The FDA Recruits British Organs-on-Chips to Speed Up Drug Development

New and Improved CRISPR: More Precise Genome Editing Now Possible

Here’s a Flashy New Technique to Model Disease

Meet John Beadle, the Serial Entrepreneur with the Key to Oncolytic Viruses

Shire’s Hemophilia Gene Therapy Boosted by Orphan Drug Designation

British Researchers Develop Clever Nanoparticles to Kill Cancer Cells

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!